NRX PHARMACEUTICALS INC's ticker is NRXPW and the CUSIP is 629444118. A total of 6 filers reported holding NRX PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 23,481 | $1,409 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,892 | $895 | 0.00% |
| Tower Research Capital LLC (TRC) | 15 | $1 | 0.00% |
| Virtu Financial LLC | 41,283 | $2 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 95 | $6 | 0.00% |
External links
This page lists NRX PHARMACEUTICALS INC's shareholders in Q2 2024. To view NRX PHARMACEUTICALS INC's shareholder history, click here.